The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP3087091
WO Application Number:
CA2014000919
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP14874710.8
WO Publication Number:
WO2015095952
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Canada (CA)
Publications:
Dates
Filing date:
29/12/2014
Grant date:
20/10/2021
EP Publication Date:
02/11/2016
WO Publication Date:
02/07/2015
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
20/10/2021
EP B1 Publication Date:
20/10/2021
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
28/12/2034
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
20/10/2021
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
20/10/2021
Name:
Zymeworks Inc.
Address:
1385 West 8th Avenue
Suite 540, Vancouver, British Columbia V6H 3V9, Canada (CA)
From:
20/10/2021
Name:
Var2 Pharmaceuticals ApS
Address:
Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark (DK)